Form 4 for SHC Sotera Health Co

Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-25 · accession 0001822479-21-000059 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2021-08-27	2021-08-25	SHC	Rutz Michael P	Pres of Sterigenics	S - Sale	$25.03	-67.0K	554.0K	-11%	-$1.68M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $0.01 par value per share ("Common Stock")	2021-08-25	S	D	67,000	$25.03	554,043	D	—	—	(F1) Represents the weighted-average share price. The lowest price at which shares were sold was $24.90 and the highest price at which shares were sold was $25.39. The Reporting Person undertakes to provide, upon request of the SEC or a security holder of the issuer, complete information regarding the number of shares sold at each price. (F2) Consists of 26,086 Restricted Stock Units ("RSUs") and 527,957 shares of Common Stock. The RSUs were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. 98,566 of the shares of Common Stock are vested, and 429,391 shares of Common Stock remain subject to vesting conditions. Shares of unvested Common Stock will vest on a daily basis, pro rata through May 13, 2025 (the five year anniversary of the date of grant).